This contract expires in 218 days (Nov 22, 2026).
FIRM FIXED PRICE
SCHAAF DRUGS, LLC - YEAR 4, OPTION YEAR 3 PATIENT RADIOPHARMACEUTICAL DRUGS (12 MONTHS)
PIID: 36C25026N0181
Signed Date: Nov 24, 2025Effective Date: Nov 23, 2025End Date: Closes in 218 days
Key Details
Description
YEAR 4, OPTION YEAR 3 PATIENT RADIOPHARMACEUTICAL DRUGS (12 MONTHS)
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.
Related
Agencies
Vendors